Keywords: Quay Pharma, Wales, UK, R&D, Clinical trials, Investment

Quay Pharmaceuticals sets up headquarters in Wales

Article | 11 November 2009

Quay Pharmaceuticals is investing £2.7million ($4.5 million) in a new headquarters and manufacturing facility in North Wales, UK, where, with support from the Welsh Assembly Government, it will create 54 new high-quality jobs. Quay, which was established in 2001 by chief executive Mike Rubinstein, a former Director of the School of Pharmacy and Chemistry at Liverpool John Moores University, is relocating from The Wirral in the Liverpool area of the UK.

O Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.

FREE unlimited, no obligation access to The Pharma Letter website for 30 days, normally worth £60!

Sign up in less than 60 seconds...no payment needed

Want to read the full article?
Take a 30 day FREE Trial worth £60

Take a no obligations 30 day trial.
Only one trial per user. Find out more details

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in